Skip to main content
Entheon Biomedical Corp. logo

Entheon Biomedical Corp. — Investor Relations & Filings

Ticker · ENBI LEI · 894500N2J7IXCCDRWU50 CSE Professional, scientific and technical activities
Open in API
Filings indexed 243 across all filing types
Latest filing 2026-04-02 Regulatory Filings
Country CA Canada
Listing CSE ENBI

About Entheon Biomedical Corp.

https://www.entheonbiomedical.com/

Entheon Biomedical Corp. is a biotechnology research and development company focused on creating therapeutic solutions for addiction and substance use disorders. The company specializes in the development and commercialization of psychedelic medicines, particularly dimethyltryptamine (DMT). Entheon aims to progress psychedelics to therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, and novel compounds tailored for treating these complex conditions.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a regulatory compliance certificate (Form 52-109FV2) by the interim CFO certifying the interim financial report and interim MD&A for the period ended February 28, 2025 under Canadian NI 52-109. It is not the interim report itself, nor an announcement of publication, nor an audit report or management discussion. It is a standalone regulatory filing form, fitting the fallback category of Regulatory Filings.
2026-04-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 venture issuer basic certificate by the CEO certifying review of the interim financial report and interim MD&A for the period ended February 28, 2026. It is a regulatory certification form required by securities legislation rather than the interim report itself or a management discussion. There is no detailed MD&A or attachments of the financial statements, nor is it an announcement that a report is available. It therefore falls into the fallback “Regulatory Filings” category.
2026-04-02 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a statutory certification (Form 52-109FV2) by the interim CFO attesting to the review and fair presentation of the issuer’s interim financial report and interim MD&A. It is not the interim financial report itself (IR) nor an announcement of a report (RPA), but rather a regulatory filing that does not fit any more specific category. Therefore it is classified as a general regulatory filing (RNS).
2026-04-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a CEO’s certification (Form 52-109FV2) of the issuer’s interim financial report and interim MD&A under Canadian NI 52-109. It is not the interim report itself or an earnings release, but rather a regulatory compliance filing. Therefore, it falls under the general “Regulatory Filings” category.
2026-04-02 English
Interim financial statements/report – English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “Notice of Meeting, Management Information Circular and Form of Proxy” for a special shareholders’ meeting to approve a Plan of Arrangement. It contains detailed proxy solicitation materials (notice, voting instructions, management circular, schedules, background and terms of the arrangement) rather than simply announcing a report or summarizing financial results. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-02 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management Discussion and Analysis” and provides management’s narrative explanation of the company’s financial position, results of operations, business trends, forward-looking statements, and corporate developments for the quarter ended February 28, 2026 (and comparative period). This matches the definition of a Management Report (MD&A).
2026-04-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.